biguanides has been researched along with Escherichia coli Infections in 5 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bilateral Acanthamoeba keratitis was diagnosed by culture using nonnutrient agar overlaid with viable Escherichia coli." | 1.36 | Bilateral acanthamoeba keratitis after orthokeratology. ( Kim, EC; Kim, MS, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noll, CV | 1 |
| Kilcoyne, I | 1 |
| Nieto, JE | 1 |
| Thio, T | 1 |
| Byrne, BA | 1 |
| Henly, EL | 1 |
| Dowling, JAR | 1 |
| Maingay, JB | 1 |
| Lacey, MM | 1 |
| Smith, TJ | 1 |
| Forbes, S | 1 |
| Baier, G | 1 |
| Cavallaro, A | 1 |
| Vasilev, K | 1 |
| Mailänder, V | 1 |
| Musyanovych, A | 1 |
| Landfester, K | 1 |
| Kim, EC | 1 |
| Kim, MS | 1 |
| Michel, D | 1 |
| Zäch, GA | 1 |
5 other studies available for biguanides and Escherichia coli Infections
| Article | Year |
|---|---|
In vitro efficacy of a 0.2% polyhexamethylene biguanide-impregnated gauze dressing against pathogenic bacterial isolates found in horses.
Topics: Animals; Bandages; Biguanides; Disinfectants; Escherichia coli; Escherichia coli Infections; Horse D | 2021 |
Biocide Exposure Induces Changes in Susceptibility, Pathogenicity, and Biofilm Formation in Uropathogenic
Topics: Animals; Anti-Bacterial Agents; Benzalkonium Compounds; Biguanides; Biofilms; Catheter-Related Infec | 2019 |
Enzyme responsive hyaluronic acid nanocapsules containing polyhexanide and their exposure to bacteria to prevent infection.
Topics: Anti-Bacterial Agents; Biguanides; Drug Carriers; Escherichia coli; Escherichia coli Infections; Hum | 2013 |
Bilateral acanthamoeba keratitis after orthokeratology.
Topics: Acanthamoeba Keratitis; Antiprotozoal Agents; Biguanides; Drug Therapy, Combination; Escherichia col | 2010 |
Antiseptic efficacy of disinfecting solutions in suspension test in vitro against methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli in pressure sore wounds after spinal cord injury.
Topics: Anti-Infective Agents, Local; Biguanides; Chamomile; Chlorhexidine; Escherichia coli; Escherichia co | 1997 |